Skip to Content for Havels Blog

Uncategorized

Havel’s Ultrasound Needles Go International at ASRA

Apr 29, 2010

Havel’s Inc. recently exhibited at the Annual Spring ASRA Meeting, in Toronto, Canada.  Havel’s EchoStim® Insulated and EchoBlock® Non-Insulated needles  for ultrasound guided peripheral nerve blocks have been available in Canada since April of 2009 from Canadian Hospital Specialties (CHS).  The needles have been selling extremely well in Canada since the release and this was the first opportunity for Havel’s to see firsthand how well received they are.  The show brought attendees from around the world, including several that were already using Havel’s needles.  The opportunity to talk with those satisfied customers was a highlight of the meeting, and hearing success stories always energizes the Havel’s team.   Many other attendees were interested in getting samples, and those new to the products were surprised to hear that Havel’s premium echogenic insulated needles came without a premium price.  Most expect to pay more for the echogenic feature and since that is not the case, the Havel’s booth was very popular.  With another great show behind us, Havel’s is now looking forward to another trip up north for the International Symposium of Ultrasound for Regional Anesthesia (ISURA) in Toronto in June.  See you then.

–John Barrett, VP Sales & Marketing for Havel’s Inc.

Dr. Elizabeth Vliet Responds to Mammogram Cutbacks

Nov 24, 2009

Physician Elizabeth Vliet, MD speaks out about rationing for women:

I am shocked and appalled at the cataclysmic shift in the guidelines to later age and less frequent mammograms. This is diametrically opposite from the American Cancer Society guidelines, and from what most oncologists and practicing physicians think is needed. I think these new guidelines are detrimental to our goals of getting early detection and prompt treatment for women with breast cancer.

Even more ominous, the recommendation to start mammograms at age 50 instead of age 40 comes at a time when physicians are seeing younger women developing breast cancer. It makes no sense to me as a women’s health physician to suddenly decide to wait until an older age to screen for breast cancer when we know that survival is improved the earlier the diagnosis is made and treatment is begun.

It makes no sense, that is, unless you realize that this change is primarily designed to cut costs, not improve women’s health. I think this is just the start of government-mandated guideline-based rationing of healthcare. As has been the case my whole career, I see that women are the first group to suffer when cost cutting takes precedent over sound medical care.

This is exactly what has been going on with the government-controlled health service in Britain! Due to cost cutting, British women can only get NHS coverage for mammograms every three years from age 50 to 70. What’s been the impact on survival rates? British women have about 20% lower survival rates with breast cancer than do American women.

Cutting back mammograms to every two years beginning at age 50 and ending at age 74 is a change made by a government sponsored panel, much like the ones being set up to decide your care under the Senate and House healthcare “reform” bills now being discussed.

Who were not involved in making these new recommendations? The very physicians you are most likely to see if you feel a lump: cancer specialists, radiologists, and primary care physicians-who are your first ally in getting prompt diagnosis.

The change in guidelines came from the distant and impersonal “review of data” from published studies. This is very different from physicians seeing patients and dealing one on one, face-to-face with the emotional trauma that comes from a cancer diagnosis. As a women’s health physician, I want the best and most timely diagnostic tools available to help my patients determine what’s wrong. I am profoundly concerned that government “experts,” far removed from the daily care of patients, are sitting “on high” to proclaim that women don’t need to start mammograms at age 40.

Even more disturbing: I think some of the reasons these experts have given are paternalistic and demeaning to women. Example: It causes “anxiety” to have a false positive mammogram. So? Women are strong. Women can handle “anxiety.” What is worse? Brief anxiety to find out a lump is not malignant (false positive)? To have the greater trauma and anxiety from waiting until age 50 to have your first mammogram, only to find you have a walnut-sized cancer that has spread to your lymph nodes?

For my patients, I am continuing to prescribe annual mammograms beginning at age 40. I believe this is sound medical practice. I believe this is in each woman’s best interest. And I am not going to stop ordering mammograms just because a woman reaches age 74. Older women are just as worthy of early diagnosis and prompt treatment as are younger women. If you are the woman who is missed because the “guideline” did not fit, it’s your life at stake.

Get Paid to Administer the H1N1 Vaccine

Sep 23, 2009

Major payers have issued coding instructions.

From the AAFP article:

CMS has created a unique health care common procedure coding system, or HCPCS, code — G9141 — specifically to cover administration of the H1N1 vaccine, although private insurers are not required to use the G code.

Click here to read the entire article.


Does Sonographic Needle Guidance Affect the Clinical Outcome of Intraarticular Injections?

Sep 4, 2009

The Avanca RPD Syringe

The Avanca RPD Syringe

In July, the Journal of Rheumatology published the article “Does Sonographic Needle Guidance Affect the Clinical Outcome of Intraarticular Injections?” Dr. William L. Sibbett, Jr. contributed to the article. Dr. Sibbett is the inventor of the Avanca syringe.

To view the abstract, click here.

To view the full article, click here.